{
  "docId": "019f6b8f-1354-774d-98d0-be219b0f6eb3",
  "docSlug": "jarvis-elliott-management-gsk-letter-july-2021",
  "documentTitle": "Elliott Management GSK Letter July 2021",
  "authorId": "elliott-management-gsk-letter-july-2021",
  "authorName": null,
  "documentKindSlug": "document",
  "documentKindLabel": "Document",
  "sourceTypeSlug": "independent_analyst",
  "sourceTypeLabel": "Independent analyst",
  "presentationDate": "2021-07-01 00:00:00",
  "orientation": null,
  "aspectRatio": null,
  "pageNumber": 11,
  "pageCount": 19,
  "prevPage": 10,
  "nextPage": 12,
  "slideType": "appendix_data",
  "function": "compare_peers",
  "density": "balanced",
  "nDataPoints": 23,
  "notes": "Includes two bar charts: 2021-2026 revenue CAGR and 2027-2030 revenue change with LOE years.",
  "elementsJson": null,
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019f6b8f-1354-774d-98d0-be219b0f6eb3/11",
  "deckHref": "/decks/019f6b8f-1354-774d-98d0-be219b0f6eb3",
  "deckJsonHref": "/decks/019f6b8f-1354-774d-98d0-be219b0f6eb3.json",
  "deckAnchorHref": "/decks/019f6b8f-1354-774d-98d0-be219b0f6eb3#slide-11",
  "components": [
    {
      "bbox": {
        "h": 0.255,
        "w": 0.764,
        "x": 0.118,
        "y": 0.555
      },
      "kind": "chart",
      "text": "Consensus 2027-2030 change in pharma revenues",
      "attrs": null,
      "subkind": "bar-vertical",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "428827bd-5b0b-44ec-a9a1-2038694327aa",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.235,
        "w": 0.764,
        "x": 0.118,
        "y": 0.232
      },
      "kind": "chart",
      "text": "2021-2026 pharma revenue CAGR",
      "attrs": null,
      "subkind": "bar-vertical",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "5040896f-7fa6-41aa-89b7-29bffec3f9ee",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.028,
        "w": 0.764,
        "x": 0.118,
        "y": 0.504
      },
      "kind": "paragraph",
      "text": "GSK's portfolio is also comparatively resilient, with its 2028 patent cliff comparing favourably to peers in terms of both timing and size.",
      "attrs": null,
      "subkind": "paragraph",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "03c3f267-f966-4fcf-92dc-5750685596fa",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.056,
        "w": 0.764,
        "x": 0.118,
        "y": 0.121
      },
      "kind": "paragraph",
      "text": "While there is still some scepticism around the long-term prospects of New GSK, it compares favourably to peers on a number of key metrics. For instance, revenue growth prospects for the next five years appear robust.",
      "attrs": null,
      "subkind": "paragraph",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "fb2df057-8821-4590-b514-3a28bb08f6cc",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.035,
        "w": 0.764,
        "x": 0.118,
        "y": 0.866
      },
      "kind": "source-note",
      "text": "9 Peer Visible Alpha consensus revenues as of 25-Jun-21, includes pharma and vaccines revenues only, GSK lower end of Company guidance, PFE revenues exclude contribution from Covid-19 vaccine. 10 Visible Alpha consensus revenues as of 25-Jun-21.",
      "attrs": null,
      "subkind": "source-note",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "efa7e252-6e22-49d5-aaa0-18df74235674",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.018,
        "w": 0.185,
        "x": 0.118,
        "y": 0.093
      },
      "kind": "title",
      "text": "Appendix II: New GSK",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "d842190f-0a1b-46cd-8d94-3500da0f2b12",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [],
  "frameworks": [],
  "arcBeats": [
    {
      "to": 11,
      "from": 10,
      "beatId": "1c482301-3d23-44a1-b294-225fd6d38013",
      "arcName": "The Consultant's Gambit",
      "arcSlug": "consultants-gambit",
      "beatName": "Evidence & Proof",
      "beatSlug": "consultants-gambit-evidence-proof",
      "evidence": "Slides 10-11 provide appendix data supporting the argument.",
      "position": 1,
      "confidence": 0.8,
      "parentBeatName": "Evidence",
      "parentBeatSlug": "evidence"
    }
  ],
  "loops": [],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}